This retrospective study is to compare the follicular mild stimulation and luteal simulation protocols for poor responders undergoing in vitro fertilization (IVF). A total of 131 women were diagnosed as poor responders. Thirty-three women started ovarian stimulation in early-luteal phase and 98 women started in early follicular phase with 100mg/d clomiphene citrate and 75-150IU/d HMG. There were more oocytes retrieved (2.82.0 versus 2.0 +/- 1.2, p<0.05), more available embryos (1.8 +/- 1.4 versus 1.3 +/- 1.1, p<0.05) and top-quality embryos (0.9 +/- 0.9 versus 0.4 +/- 0.6, p<0.05), and reduced cycle cancellation rate (12.1% versus 30.6%, p<0.05) in luteal group than in follicular group. The clinical pregnancy (17.7%, 20.0% and 4...
Aim: To compare the effect of clomiphene citrate (CC) + human menopausal gonadotropin (hMG) with let...
Aim: Luteal phase support has been demonstrated as being necessary in patients undergoing IVF/ET aft...
Background: Ovulatory dysfunction is a common cause of female infertility, occurring in up to 20 - 3...
International audienceBackground: In patients treated with IVF, the incidence of poor ovarian respon...
We examined whether treatment with minimum-dose stimulation (MS) protocol enhances clinical pregnanc...
Objective: To compare two protocols of CC therapy for induction of ovulation in a group CC resistant...
Background: Poor ovarian response management is a complex and controversial issue in the field of re...
Objective: To assess the clinical contribution of luteal-phase stimulation (LPS) to follicular-phase...
Purpose: To compare the efficacy of different stimulation protocols on pregnancy outcomes in poor re...
Introduction: Luteal phase ovarian stimulation (LPOS) has been proven a feasible protocol for infe...
This study aimed to standardize the clomiphene citrate test (CC-t) in our laboratory while comparing...
Background/aim: The aim of the study was to compare the luteal estradiol patch/GnRH antagonists prim...
Introduction: Between 5±18% of patients presents a low response when stimulated for IVF cycles. The ...
This study compares the results of three ovulation induction protocols in polycystic ovarian disease...
STUDY QUESTION: Are cumulative and live birth rates (LBRs) comparable in poor ovarian response women...
Aim: To compare the effect of clomiphene citrate (CC) + human menopausal gonadotropin (hMG) with let...
Aim: Luteal phase support has been demonstrated as being necessary in patients undergoing IVF/ET aft...
Background: Ovulatory dysfunction is a common cause of female infertility, occurring in up to 20 - 3...
International audienceBackground: In patients treated with IVF, the incidence of poor ovarian respon...
We examined whether treatment with minimum-dose stimulation (MS) protocol enhances clinical pregnanc...
Objective: To compare two protocols of CC therapy for induction of ovulation in a group CC resistant...
Background: Poor ovarian response management is a complex and controversial issue in the field of re...
Objective: To assess the clinical contribution of luteal-phase stimulation (LPS) to follicular-phase...
Purpose: To compare the efficacy of different stimulation protocols on pregnancy outcomes in poor re...
Introduction: Luteal phase ovarian stimulation (LPOS) has been proven a feasible protocol for infe...
This study aimed to standardize the clomiphene citrate test (CC-t) in our laboratory while comparing...
Background/aim: The aim of the study was to compare the luteal estradiol patch/GnRH antagonists prim...
Introduction: Between 5±18% of patients presents a low response when stimulated for IVF cycles. The ...
This study compares the results of three ovulation induction protocols in polycystic ovarian disease...
STUDY QUESTION: Are cumulative and live birth rates (LBRs) comparable in poor ovarian response women...
Aim: To compare the effect of clomiphene citrate (CC) + human menopausal gonadotropin (hMG) with let...
Aim: Luteal phase support has been demonstrated as being necessary in patients undergoing IVF/ET aft...
Background: Ovulatory dysfunction is a common cause of female infertility, occurring in up to 20 - 3...